Marshall G Miles, DO | |
1243 S Cedar Crest Blvd, Suite 301, Allentown, PA 18103-6268 | |
(610) 402-4375 | |
(610) 402-4256 |
Full Name | Marshall G Miles |
---|---|
Gender | Male |
Speciality | Plastic And Reconstructive Surgery |
Experience | 22 Years |
Location | 1243 S Cedar Crest Blvd, Allentown, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205006988 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | OS013989 (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Lehigh Valley Hospital | Allentown, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Lehigh Valley Physician Group | 3072425123 | 1763 |
News Archive
Aradigm Corporation today announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE) under a U.S. IND. This orphan disease indication is a chronic, severe respiratory disease and there are currently no approved treatments for this disease in the U.S.
This year, the American Cancer Society estimates over 230,000 new cases of invasive breast cancer will be diagnosed in women.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at Massachusetts General Hospital (MGH), the Broad Institute, and the David H. Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT), today announced new findings published in Nature.
Heart failure is a progressive condition, where structural and functional alterations of the ventricle limit the ability of the heart to either fill or eject blood. There are approximately 550,000 new cases of heart failure each year with a prevalence of nearly 5 million; most patients die within five years of diagnosis.
› Verified 3 days ago
Entity Name | Lehigh Valley Physician Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
Aradigm Corporation today announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE) under a U.S. IND. This orphan disease indication is a chronic, severe respiratory disease and there are currently no approved treatments for this disease in the U.S.
This year, the American Cancer Society estimates over 230,000 new cases of invasive breast cancer will be diagnosed in women.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at Massachusetts General Hospital (MGH), the Broad Institute, and the David H. Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT), today announced new findings published in Nature.
Heart failure is a progressive condition, where structural and functional alterations of the ventricle limit the ability of the heart to either fill or eject blood. There are approximately 550,000 new cases of heart failure each year with a prevalence of nearly 5 million; most patients die within five years of diagnosis.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Marshall G Miles, DO Po Box 783311, Philadelphia, PA 19178-3311 Ph: () - | Marshall G Miles, DO 1243 S Cedar Crest Blvd, Suite 301, Allentown, PA 18103-6268 Ph: (610) 402-4375 |
News Archive
Aradigm Corporation today announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE) under a U.S. IND. This orphan disease indication is a chronic, severe respiratory disease and there are currently no approved treatments for this disease in the U.S.
This year, the American Cancer Society estimates over 230,000 new cases of invasive breast cancer will be diagnosed in women.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at Massachusetts General Hospital (MGH), the Broad Institute, and the David H. Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT), today announced new findings published in Nature.
Heart failure is a progressive condition, where structural and functional alterations of the ventricle limit the ability of the heart to either fill or eject blood. There are approximately 550,000 new cases of heart failure each year with a prevalence of nearly 5 million; most patients die within five years of diagnosis.
› Verified 3 days ago
Andrew Steele, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 484-862-3256 | |
Dr. Geoffrey Gaddis Hallock, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1230 S Cedar Crest Blvd, Suite 306, Allentown, PA 18103 Phone: 610-435-7555 | |
Dr. Samina Wahhab, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1255 S Cedar Crest Blvd Suite 1100, Allentown, PA 18103 Phone: 610-770-7676 Fax: 610-770-1412 | |
Badar Jan, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 250 Cetronia Rd, Suite 301, Allentown, PA 18104 Phone: 610-437-2378 Fax: 610-820-9983 | |
Sigrid Blome-eberwine, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1240 S Cedar Crest Blvd, Suite 308, Allentown, PA 18103 Phone: 610-402-1350 Fax: 610-402-1356 | |
Jessica Rene Cunning, MD, MBA Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 484-862-3256 |